Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Point-of-care HCV Assays: A Turning Point for Decentralized Diagnosis
-
- 10 Recent Advances in Crohn’s and Colitis Research
- FDA Approves Xeljanz for Moderate-to-Severe UC
- Flexibility Key in Diagnosing, Managing IBS Edward V. Loftus Jr., MD
- AASLD Online HCV Guide Update Includes Key At-risk Populations
- 9 Things to Know About Medical Therapies for IBS
- GI psychologists bring value to IBS patient care
- IBS: Transitioning from a Syndrome to a Disease William D. Chey, MD, AGAF, FACG
- Why a GI Dietitian Adds Value to a GI Practice Kate Scarlata, MPH, RDN
-
- Colon Cancer Risk Depends on Polyp Type Found During Colonoscopy
- Drinking Sweetened Beverages Does Not Appear to Increase IBD Risk
- Gut Microbiome Linked to Artery Health
- Rare Skin Condition Linked to Crohn’s Disease
- Antacid, Aspirin Combination Slows Disease Progression in Barrett’s Esophagus
- Genomic Marker Linked to Lynch Syndrome Across Cancer Types
- Low Vitamin D Levels Appear to Follow, Not Cause, Crohn’s Disease
- Microbiome Therapy Induces Remission in Mild-to-moderate UC
-
- Most Who Avoid Gluten Lack Symptoms of Intolerance, Sensitivity
- New Drug May Protect Celiac Patients From Inadvertent Gluten Exposure
- Novel Questionnaire May Help Assess Quality of Life in IBD
- $2.4 Million Grant to Fund Trial Comparing IBD Therapies
- AGA Working Group to Address Myths About IBD, Pregnancy
- FDA Warns 53 Websites to Stop Marketing Illegal Opioids
- GI Leader to Expand Specialty Medical Home Care Model